Señales en vivo de BXRX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 feb 2024 @ 15:53):

Stats
Volumen de hoy	310 872
Volumen promedio	424 847
Capitalización de mercado	950 330
EPS	$0 ( 2024-03-07 )
Próxima fecha de ganancias	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.000232
ATR14	$0.00100 (4.59%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-09	Mcandrew Natalie	Buy	0
2023-07-03	Kim Yong Chan	Sell	0	Common Stock
2023-07-03	Kim Yong Chan	Sell	4 520 066	Series X Preferred Stock
2022-12-15	Henwood Geraldine	Buy	1 200	Common Stock
2022-06-15	Ashton William	Buy	39 473	Common Stock

INSIDER POWER
-98.49
Last 86 transactions
Buy: 13 000 393 \| Sell: 13 896 192

Baudax Bio Inc Correlación

10 Correlaciones Más Positivas
RMRM	0.959
TANH	0.956
GNUS	0.956
MOTS	0.95
BLUE	0.934
HYW	0.934
VERB	0.928
RLAY	0.925
BNTX	0.922
AGIL	0.913

10 Correlaciones Más Negativas
LMRK	-0.96
AGFS	-0.951
QADA	-0.93
RMBS	-0.929
LOPE	-0.927
EYEG	-0.923
STTK	-0.919
SNSR	-0.91
KE	-0.91
GRID	-0.908

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Baudax Bio Inc Finanzas

Annual	2022
Ingresos:	$1.27M
Beneficio Bruto:	$-5.74M (-452.32 %)
EPS:	$-177.30

FY	2022
Ingresos:	$1.27M
Beneficio Bruto:	$-5.74M (-452.32 %)
EPS:	$-177.30

FY	2021
Ingresos:	$1.08M
Beneficio Bruto:	$-1.37M (-126.39 %)
EPS:	$-2 287 839

FY	2020
Ingresos:	$493 000
Beneficio Bruto:	$-1.24M (-251.32 %)
EPS:	$-8 806 947

Financial Reports:

No articles found.

Baudax Bio Inc

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Actualizaciones en tiempo real para Baudax Bio Inc [BXRX]

Upcoming Earnings Alert